Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. [PDF]
Malignant gliomas carry a dismal prognosis. Conventional treatment using chemo- and radiotherapy has limited efficacy with adverse events. Therapy with genetically engineered T-cells, such as chimeric antigen receptor (CAR) T-cells, may represent a ...
Almeida, Neil D +4 more
core
Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. [PDF]
Elgehiny A +14 more
europepmc +1 more source
Scratching the surface of targeting GPC2 on pediatric CNS tumors. [PDF]
Pan H, Foster JB, Bosse KR.
europepmc +1 more source
Current landscape of immunotherapy for CNS tumors. [PDF]
Landry AP, Dunn GP, Lim M.
europepmc +1 more source
An update from the Pediatric Proton Consortium Registry [PDF]
et al,, Perkins, Stephanie M
core +1 more source
Domain-Adaptive MRI Learning Model for Precision Diagnosis of CNS Tumors. [PDF]
Abdelbaki W +5 more
europepmc +1 more source
Presentation and Outcomes of CNS Tumors Associated With Phakomatoses Syndromes From a Specialized Neuro-Oncology Practice in India. [PDF]
Krishnan A +10 more
europepmc +1 more source
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants. [PDF]
Kohanbash G +14 more
europepmc +1 more source
Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review. [PDF]
Kutuk T +15 more
europepmc +1 more source

